GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...
One of the earliest proponents of evidence-based medicine, Professor David Sackett, wrote, “Good doctors use both individual ...
Researchers have developed a way of bioprinting tissues that change shape as a result of cell-generated forces, in the same way that it happens in biological tissues during organ development. The ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
RFK Jr.'s comments about the gene-editing technology raise a question about how he would regulate it as head of HHS.
Some antibiotics, antivirals, vaccinations and anti-inflammatory medications are linked to a reduced risk of dementia, a ...
Jayqwan Hamilton, 37, Robert DeMaio, 36, and Jacob Barroso, 32 -- shuffled into a Manhattan courtroom for the first day of a ...
The blood–brain barrier is the biggest challenge to the development of drugs that target the CNS. Most capillary beds leak plasma contents between and across endothelial cells by way of window-like ...
Three men have been accused of murder as part of a plot to drug and rob revelers in Midtown in 2022. Two of their targets ...
President Donald Trump's initial executive orders target previous efforts to reduce health care costs, pandemic preparedness, ...
Cebranopadol, a dual-NMR agonist, reached the primary endpoint in a Phase III trial and matched placebo for safety, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback